Suppr超能文献

老年消化性溃疡愈合缓慢的标志物。一项对1052例接受雷尼替丁治疗患者的研究。

Markers of slow-healing peptic ulcer in the elderly. A study on 1,052 ranitidine-treated patients.

作者信息

Battaglia G, Di Mario F, Dotto P, Leandro G, Pilotto A, Ferrana M, Vianello F, Vigneri S, Colonna C V, Naccarato R

机构信息

Servizio di Gastroenterologia, Ospedale, SS. Giovanni e Paolo, Venezia.

出版信息

Dig Dis Sci. 1993 Aug;38(8):1414-21. doi: 10.1007/BF01308597.

Abstract

Little is known about ulcer outcome in the elderly. The aims of the present paper were to establish whether risk factors of slow-healing peptic ulcer can be demonstrated in the elderly and whether clinical differences exist between ulcer patients whose age of onset of the disease was before or after 65 years old. The short-term, open study, involving 1052 elderly patients (over 65 years) in 37 gastroenterology centers throughout Italy aimed to compare two schedules of ranitidine treatment: 150 mg twice daily versus 300 mg at bedtime. As nonsignificant differences were found between these two schedules, the sample was considered as a whole. It included 319 gastric ulcer (GU) patients, 699 duodenal ulcer (DU) patients, and 34 concomitant GU and DU cases. Ninety-three patients dropped out of the trial; 79/294 GU, 138/635 DU, and 10/30 GU+DU were found still unhealed after four weeks and 20 GU, 15 DU, and 1 GU+DU remained so after eight weeks. Statistical analysis was performed using likelihood-ratio and Pearson's chi-squared tests and Cox's models. Univariate analysis showed that the indicators of slow-healing GU were ulcer size (P = 0.002) and persisting ulcer symptoms (P = 0.0001); indicators of slow-healing DU were ulcer size (P = 0.0001), persisting ulcer symptoms (P = 0.0001), alcohol (P = 0.0003), and NSAID (P = 0.0088) consumption. DU patients taking antiplatelet drugs have significantly better results after four weeks and worse results after eight weeks (P = 0.0352).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

关于老年人溃疡的转归情况,人们了解甚少。本文的目的是确定能否在老年人中证实消化性溃疡愈合缓慢的危险因素,以及疾病发病年龄在65岁之前或之后的溃疡患者之间是否存在临床差异。这项短期、开放性研究涉及意大利37个胃肠病学中心的1052名老年患者(65岁以上),旨在比较两种雷尼替丁治疗方案:每日两次150毫克与睡前300毫克。由于这两种方案之间未发现显著差异,因此将样本作为一个整体进行考虑。其中包括319例胃溃疡(GU)患者、699例十二指肠溃疡(DU)患者以及34例同时患有GU和DU的病例。93名患者退出试验;4周后仍未愈合的患者有79/294例GU、138/635例DU以及10/30例GU+DU,8周后仍未愈合的患者有20例GU、15例DU以及1例GU+DU。使用似然比、Pearson卡方检验和Cox模型进行统计分析。单因素分析表明,GU愈合缓慢的指标是溃疡大小(P = 0.002)和持续的溃疡症状(P = 0.0001);DU愈合缓慢的指标是溃疡大小(P = 0.0001)、持续的溃疡症状(P = 0.0001)、饮酒(P = 0.0003)以及使用非甾体抗炎药(NSAID)(P = 0.0088)。服用抗血小板药物的DU患者在4周后结果显著更好,但在8周后结果更差(P = 0.0352)。(摘要截选至250词)

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验